BELL-KENZ Pharma on Tuesday rejected claims that it utilizes a multi-level marketing plan to offer its medications as the Senate started its query into reports that the business provides medical professionals high-end automobiles as a reward for recommending its medications.
The rejection was provided by Bell-Kenz president Dr. Luis Go before the Senate Committee on Health led by Sen. Bong Go.
Register to read this story and more for complimentary
Registering for an account assists us enhance your surfing experience.
OR
See our membership choices.
Currently have an account? Visit here
This site utilizes cookies. By continuing to search the site, you are accepting our usage of cookies.
Find out more.